ChronoScale Holdings Corporation (CHRN) USD0.001

Sell:$16.40Buy:$16.91Price decreased$1.15 (6.52%)

Market closed |
Prices delayed by at least 15 minutes
Sell:$16.40
Buy:$16.91
Change:Price decreased$1.15 (6.52%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$16.40
Buy:$16.91
Change:Price decreased$1.15 (6.52%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.

Key people

Wesley Cummins
Chairman of the Board
Ying Cenly Chen
Chief Executive Officer, Director
Jerome Wong
Chief Financial Officer, Corporate Secretary
Raj Jegannathan
Chief Technology Officer
Scott G. Davis
Director
Andrew Cordell Schaap
Director
Ella Gendel Benson
Independent Director
William M. Clancy
Independent Director
Douglas S. Miller
Independent Director
Click to see more

Key facts

  • Shares in issue
    143.83m
  • EPIC
    CHRN
  • ISIN
    US1709241046
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $2.54bn
  • Employees
    50
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.